* ANNOUNCED ON TUESDAY NOVEL METHODS TO IMPROVE THE CLINICAL USE OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
* ANNOUNCED DEVELOPMENT OF AN ALL-IN-ONE CHIMERIC ANTIGEN RECEPTOR (CAR) ARCHITECTURE WITH AN EMBEDDED MULTI-FUNCTIONAL TAG FOR PURIFICATION, DETECTION AND ELIMINATION OF CAR T-CELLS
Source text for Eikon:
Further company coverage: (Gdynia Newsroom)